AGF Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.21M Buy
14,374
+2,821
+24% +$927K 0.02% 290
2025
Q4
$4.05M Sell
11,553
-986
-8% -$333K 0.02% 282
2025
Q3
$4.05M Buy
12,539
+2,247
+22% +$699K 0.02% 301
2025
Q2
$4M Sell
10,292
-1,403
-12% -$564K 0.02% 282
2025
Q1
$5.09M Buy
11,695
+1,913
+20% +$768K 0.03% 256
2024
Q4
$3.61M Buy
9,782
+924
+10% +$387K 0.02% 300
2024
Q3
$4.61M Buy
8,858
+2,114
+31% +$1.13M 0.02% 274
2024
Q2
$3.65M Sell
6,744
-209
-3% -$110K 0.02% 278
2024
Q1
$3.61M Buy
6,953
+5,674
+444% +$2.82M 0.02% 295
2023
Q4
$603K Sell
1,279
-333
-21% -$154K ﹤0.01% 609
2023
Q3
$702K Buy
+1,612
New +$731K 0.01% 598
2023
Q2
Sell
-2,118
Closed -$974K 703
2023
Q1
$974K Buy
2,118
+252
+14% +$120K 0.01% 589
2022
Q4
$957K Buy
+1,866
New +$947K 0.01% 597

Other funds holding ELV

AGF Management's ELV Position: Q1 2026 in Review

AGF Management increased its Elevance Health (ELV) stake by 24% in Q1 2026, buying an estimated $927K and bringing the position to 14,374 shares worth $4.21M. The position accounts for 0.02% of the portfolio, ranked #290.

AGF Management first reported a position in ELV in Q4 2022 and has held it in 13 quarters since. The position peaked at $5.09M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • AGF Management held 14,374 shares of Elevance Health worth $4.21M as of Q1 2026.
  • AGF Management bought 2,821 Elevance Health shares in Q1 2026, an estimated $927K.
  • Elevance Health made up 0.02% of AGF Management's portfolio in Q1 2026, its #290 holding.
  • AGF Management first reported a position in Elevance Health in Q4 2022 and has held it in 13 quarters since.
  • AGF Management's Elevance Health position peaked at $5.09M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.